Breast Cancer Advice Center

Metastatic Breast Cancer News

Avastin Plus Commonly Used Chemotherapies Demonstrated Improved Progression-Free Survival in Advanced Breast Cancer (Centre Daily Times)Mon, 24 Nov 2008 06:52:55 GMTGenentech, Inc. (NYSE:DNA) today announced that a Phase III study (RIBBON 1) of Avastin ® (bevacizumab), in combination with taxane, anthracycline-based or capecitabine chemotherapies for first-line treatment of metastatic HER2-negative breast cancer, met its primary endpoint of increasing the time patients lived without their disease advancing, compared to the chemotherapies alone. The primary ...

Study boosts Roche's Avastin in breast cancer (Reuters via Yahoo! News)Mon, 24 Nov 2008 14:32:28 GMT * Avastin meets goal in breast cancer clinical trial

Bionovo to present phase 1B trial results of BZL101 in metastatic breast cancer (News-Medical-Net)Fri, 21 Nov 2008 21:56:37 GMTBionovo, Inc. has announced the company will present results from the Phase 1B clinical trial of their lead drug candidate for advanced metastatic breast cancer, BZL101, at the Society for Integrative Oncology's Fifth International Conference in Atlanta, Georgia.

Can some breast cancer tumors regress if left untreated? (CNN)Tue, 25 Nov 2008 19:28:34 GMTDo more frequent mammograms pick up some breast cancer tumors that might have gone away without treatment? Possibly, according to a controversial study published this week in Archives of Internal Medicine. However, experts caution that the research raises an interesting question, but can't definitively answer it.

Avastin Plus Commonly Used Chemotherapies Demonstrated Improved Progression-Free Survival In Advanced Breast Cancer (Medical News Today)Mon, 24 Nov 2008 19:21:21 GMTGenentech, Inc. (NYSE:DNA) today announced that a Phase III study (RIBBON 1) of Avastin® (bevacizumab), in combination with taxane, anthracycline-based or capecitabine chemotherapies for first-line treatment of metastatic HER2-negative breast cancer, met its primary endpoint of increasing the time patients lived without their disease advancing, compared to the chemotherapies alone.